Construction of a gene-based diagnostic model for prostate cancer and AI-guided drug prediction coupled with molecular docking
Authors: Du, Guowang; Qiu, Yu; Wang, Hao; Ma, Huangbin
Source journal: BMC urology (2026-08-26)
DOI: 10.1186/s12894-026-02327-7
Abstract
OBJECTIVE: To construct a gene-based diagnostic model for prostate cancer and to predict potential therapeutics using artificial intelligence (AI) based on datasets from the GEO database. METHODS: Differential gene expression analysis was performed between tumor and normal samples using expression matrices. Weighted gene co-expression network analysis (WGCNA) was applied to the corrected expression data to identify modules of co-expressed genes. The intersection of significantly differentially expressed genes and WGCNA-derived genes was subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. A protein-protein interaction (PPI) network was constructed from the intersecting genes, and the top five hub genes, ranked by degree of connectivity, were used to develop and validate a diagnostic model for prostate cancer. Finally, AI-driven drug prediction was conducted using the gene expression profiles. RESULTS: A total of 516 differentially expressed genes and 3,392 WGCNA-derived co-expressed genes were identified, yielding 465 intersecting genes associated with prostate cancer. GO enrichment analysis revealed significant involvement in oxygen level response, collagen-containing extracellular matrix, and enzyme inhibitor activity. KEGG pathway analysis indicated enrichment in cancer-related pathways, including prostate cancer, hepatocellular carcinoma, drug metabolism (CYP450), Wnt signaling, AMPK signaling, and oxidative stress-related pathways. In the PPI network, the top five hub genes-ANXA2, GJA1, PIK3R1, CAV1, and MYC-demonstrated strong diagnostic performance in the prostate cancer prediction model. AI-based prediction identified AGI-5198 as a candidate therapeutic agent. CONCLUSION: ANXA2, GJA1, PIK3R1, CAV1, and MYC represent key predictive genes for prostate cancer diagnosis, while AGI-5198 emerges as a promising AI-predicted therapeutic candidate.
Related topics
Related open access articles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- DENSITY FUNCTIONAL THEORY ANALYSIS AND MOLECULAR DOCKING EVALUATION OF 8-CHLOROQUINOLINE 2-CARBALDEHYDE
- Thermochemical, DFT, Molecular Docking and Pharmacokinetic Studies of Methyl β-D-galactopyranoside Esters
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.